(Q34115527)

31 July 2017

title

Therapy-associated effects in the prostate gland (English)

1 reference

31 July 2017

2

Brett Delahunt

1 reference

31 July 2017

John R Srigley

1

1 reference

31 July 2017

Andrew J Evans

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

60

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

153-165

1 reference

Granulomatous prostatitis: distinction among allergic, nonspecific, and post-transurethral resection lesions

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Treatment strategies for high-risk locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

CyberKnife Radiosurgery for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Treatment effects in the prostate including those associated with traditional and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

STUDIES ON PROSTATIC CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Chemoprevention of prostate cancer: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

High-grade prostate cancer and finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

New drug development in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Castration-refractory prostate cancer: New drugs in the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Targeted therapy of cancer: new roles for pathologists--prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Focal therapy in prostate cancer: modalities, findings and future considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Cryotherapy for prostate cancer: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Focal therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

High intensity focused ultrasound for the treatment of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04079.X

10.1111/J.1365-2559.2011.04079.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference